Mepinaest Purum

Mepivacaine Hydrochloride, the active ingredient in Mepinaest Purum, is a local anesthetic (amide type) presented as a sterile solution for intramuscular use. It provides reversible nerve blockade for dental work, minor surgeries and other procedures requiring short‑term local anesthesia.

GNH USA supplies Mepinaest Purum as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Mepivacaine Hydrochloride is used to provide local anesthesia in procedures involving the peripheral nervous system.

- Dental procedures: provides local anesthesia to facilitate pain‑free treatment of teeth and surrounding tissues. - Minor surgical procedures: produces reversible loss of sensation to allow incision and suturing without discomfort. - Minor orthopedic interventions: enables temporary numbness for small joint or soft‑tissue manipulations.

Mepivacaine Hydrochloride may cause a range of adverse reactions, most of which are mild and transient.

Common Side Effects: - Injection site pain or burning sensation. - Transient numbness or tingling beyond the intended area. - Dizziness or light‑headedness. - Metallic taste in the mouth. - Mild tachycardia. - Temporary hypotension.

Serious or Rare Side Effects: - Seizures or convulsive activity. - Severe cardiac arrhythmias, including ventricular tachycardia. - Anaphylactic or severe allergic reactions. - Methemoglobinemia. - Persistent neurological deficits. - Cardiovascular collapse.

Prior to administration, clinicians should evaluate patient‑specific risk factors and follow standard safety protocols.

- Allergy assessment: verify no known hypersensitivity to amide‑type local anesthetics. - Cardiovascular status: monitor patients with existing heart disease or conduction abnormalities. - Dosage limits: avoid exceeding the recommended maximum dose for the patient’s weight and age. - Concurrent CNS depressants: use caution when combined with other agents that lower seizure threshold. - Pregnancy and lactation: assess risk–benefit as safety data are limited. - Store below 25°C: keep in the original container, protect from moisture and light.

Mepivacaine Hydrochloride can interact with several drug classes, influencing its safety profile.

Major Interactions (Avoid): - Class I antiarrhythmics (e.g., quinidine, procainamide): may increase plasma concentrations of mepivacaine. - Monoamine oxidase inhibitors (MAOIs): risk of severe hypertension. - Beta‑blockers combined with epinephrine: may potentiate cardiovascular effects.

Moderate Interactions (Monitor Closely): - Other local anesthetics: additive toxicity risk. - Central nervous system depressants (e.g., benzodiazepines, opioids): may enhance CNS depression. - Diuretics: may alter plasma protein binding and affect drug levels.